Quertle Releases Qinsight — a Biomedical Literature Discovery Product Built on Its BioAI Artificial …

HENDERSON, Nev.–(BUSINESS WIRE)–Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI™), has released Qinsight™. The product uses BioAI’s neural networks and other AI methods, along with predictive visual analytics, to enable high-efficiency discovery and insight from biomedical literature. The visual analytics in Qinsight™ provide summarization, discover emerging trends and uncover hidden connections. These capabilities overcome many of the problems of list-oriented results, which make information assimilation nearly impossible. Qinsight™ covers more than 40 million documents, including searching the full text of more than 10 million. The content includes, essentially, all biomedical and biological journals, patent grants and applications, NIH grant applications, TOXLINE databases, AHRQ treatment protocols, and more, which, along with the AI underpinnings, gives a deeper perspective than that available anywhere else.…


Link to Full Article: Quertle Releases Qinsight — a Biomedical Literature Discovery Product Built on Its BioAI Artificial …